Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on April 30, 2004
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
279/18/18851    most recent
M312795200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lagace, D. C.
Right arrow Articles by Nachtigal, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lagace, D. C.
Right arrow Articles by Nachtigal, M. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print February 24, 2004
J. Biol. Chem, 10.1074/jbc.M312795200
Submitted on November 24, 2003
Revised on February 18, 2004
Accepted on February 24, 2004

Inhibition of histone deacetylase activity by valproic acid blocks adipogenesis

Diane C. Lagace and Mark W. Nachtigal

Pharmacology, Dalhousie University, Halifax, NS B3H 1X5

Corresponding Author: Mark.Nachtigal{at}Dal.Ca

Adipogenesis is dependent on the sequential activation of transcription factors including the CCAAT/enhancer binding proteins (C/EBP), peroxisome proliferator-activated receptor gamma (PPAR gamma ), and steroid regulatory element binding protein (SREBP). We show that the mood stabilizing drug valproic acid (VPA; 0.5-2 mM) inhibits mouse 3T3 L1 and human preadipocyte differentiation, likely through its histone deacetylase (HDAC) inhibitory properties. The HDAC inhibitor trichostatin A (TSA) also inhibited adipogenesis, whereas the VPA analog valpromide (VPM), which does not possess HDAC inhibitory effects, did not prevent adipogenesis. Acute or chronic VPA treatment inhibited differentiation yet did not affect mitotic clonal expansion. VPA (1 mM) inhibited PPAR gamma induced differentiation, but does not activate a PPAR gamma reporter gene, suggesting it is not a PPAR gamma ligand. VPA or TSA treatment reduced mRNA and protein levels of PPAR gamma , SREBP1a. TSA reduced C/EBP alpha mRNA and protein levels, whereas VPA only produced a decrease in C/EBP alpha protein expression. Overall our results highlight a role for HDAC activity in adipogenesis that can be blocked by treatment with VPA.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Hisahara, S. Chiba, H. Matsumoto, M. Tanno, H. Yagi, S. Shimohama, M. Sato, and Y. Horio
From the Cover: Histone deacetylase SIRT1 modulates neuronal differentiation by its nuclear translocation
PNAS, October 7, 2008; 105(40): 15599 - 15604.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. M. Musri, H. Corominola, R. Casamitjana, R. Gomis, and M. Parrizas
Histone H3 Lysine 4 Dimethylation Signals the Transcriptional Competence of the Adiponectin Promoter in Preadipocytes
J. Biol. Chem., June 23, 2006; 281(25): 17180 - 17188.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Qiao, J. Schaack, and J. Shao
Suppression of Adiponectin Gene Expression by Histone Deacetylase Inhibitor Valproic Acid
Endocrinology, February 1, 2006; 147(2): 865 - 874.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Kawamura, K. Ono, T. Morimoto, H. Wada, M. Hirai, K. Hidaka, T. Morisaki, T. Heike, T. Nakahata, T. Kita, et al.
Acetylation of GATA-4 Is Involved in the Differentiation of Embryonic Stem Cells into Cardiac Myocytes
J. Biol. Chem., May 20, 2005; 280(20): 19682 - 19688.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Fu, M. Rao, T. Bouras, C. Wang, K. Wu, X. Zhang, Z. Li, T.-P. Yao, and R. G. Pestell
Cyclin D1 Inhibits Peroxisome Proliferator-activated Receptor {gamma}-mediated Adipogenesis through Histone Deacetylase Recruitment
J. Biol. Chem., April 29, 2005; 280(17): 16934 - 16941.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
J. E. Celis, J. M. A. Moreira, T. Cabezon, P. Gromov, E. Friis, F. Rank, and I. Gromova
Identification of Extracellular and Intracellular Signaling Components of the Mammary Adipose Tissue and Its Interstitial Fluid in High Risk Breast Cancer Patients: Toward Dissecting The Molecular Circuitry of Epithelial-Adipocyte Stromal Cell Interactions
Mol. Cell. Proteomics, April 1, 2005; 4(4): 492 - 522.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. C. Lagace, R. S. McLeod, and M. W. Nachtigal
Valproic Acid Inhibits Leptin Secretion and Reduces Leptin Messenger Ribonucleic Acid Levels in Adipocytes
Endocrinology, December 1, 2004; 145(12): 5493 - 5503.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement